Skip to main content
. 2019 Sep 22;14(4):299–304. doi: 10.30699/ijp.2019.96713.1952

Table 3.

Comparison of FGFR1 over-expression according to tumor grade and stage of 84 patients with TNBCs

FGFR1 gene amplification
P-value
Positive Negative
Tumor grade 1 2 (2.3%) 5 (6%) 0.640
2 5 (5.95%) 30 (35.71%)
3 8 (9.52%) 34 (40.47%)
Stage 1 0 2 (2.3%) 0.116
2 8 (9.52%) 28 (33.33%)
3 5 (5.95%) 30 (35.71%)
4 2 (2.3%) 9 (10.71%)